HomeVideoChanging Treatment Paradigm in Diabetes

Changing Treatment Paradigm in Diabetes

In this segment, Stephen A. Brunton, MD, FAAFP; Rosemarie Lajara, MD, FACE; Christian T. Ruff, MD, MPH; Peter L. Salgo, MD; and Karol E. Watson, MD, PhD, FACC, provide insight regarding the future role of dipeptidyl peptidase 4 inhibitors and thiazolidinediones, given the cardiovascular benefits with other medication classes.


Previous post
Diabetes Type 1 and Potassium
Next post
Th5 Giant with Healer and Archer farming strategy 2017

Leave a Reply

Be the First to Comment!

Notify of